Treat AFib ‘Diagnosed’ by Smartwatch? | Impact Factor

madman

Super Moderator
To view this content we will need your consent to set third party cookies.
For more detailed information, see our cookies page.

We discuss a fascinating case: a 77-year-old man diagnosed with AFib using traditional methods, compared to how this condition is now often identified through smartwatch notifications. This shift raises important questions about the implications of early detection of subclinical AFib — a state where patients are often asymptomatic.




Key Topics Explored:



* The evolution of AFib diagnosis: from symptoms to smartwatch alerts


* The risks and benefits of anticoagulant treatment for subclinical AFib


* Insightful findings from the ARTESIA and NOAH-AFNET 6 randomized trials


* Innovative research that compares quality of life outcomes for patients with and without treatment


* The ethical implications of direct-to-consumer health monitoring and its influence on patient care


* With data suggesting that treatment may yield minimal benefits in quality of life while posing real risks, we delve deep into the complexities of making informed medical decisions in this new landscape.
 








 

Online statistics

Members online
2
Guests online
125
Total visitors
127

Latest posts

Back
Top